secwatch.observer — SEC 8-K summary
======================================

Issuer:     STAAR SURGICAL CO (STAA)
CIK:        0000718937
Form:       8-K
Filed at:   2024-03-12T23:59:59+00:00
Accession:  0000950170-24-029647
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STAAR Surgical appoints two new directors; board expands to eight
-----------------------------------------------------------------

- Arthur Butcher (Boston Scientific EVP, MedSurg & APAC) and Wei Jiang (retired Bayer EVP) join board effective March 12, 2024.
- Board increased from 6 to 8 directors; will reduce to 7 after K. Peony Yu's term ends in June 2024.
- Butcher brings med-device marketing and APAC expertise; Jiang brings 25+ years pharma/device experience with China focus.
- Director Yu will not stand for re-election at 2024 annual meeting; board thanks her for over 3 years of service.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/718937/000095017024029647/0000950170-24-029647-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/718937/000095017024029647/staa-20240310.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-029647

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer